Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung: Final analysis of the randomised phase 3 LUX-Lung 8 trial-Reference-Cited by-同舟云学术

Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung: Final analysis of the randomised phase 3 LUX-Lung 8 trial

Published:2021-07 Issue: Volume:37 Page:100940
ISSN:2589-5370
Container-title:EClinicalMedicine
language:en
Short-container-title:EClinicalMedicine

Author:

Goss Glenwood D.,Cobo Manuel,Lu Shun,Syrigos Konstantinos,Lee Ki Hyeong,Göker Erdem,Georgoulias Vassilis,Isla Dolores,Morabito Alessandro,Min Young J.,Ardizzoni Andrea,Bender Shaun,Cseh Agnieszka,Felip Enriqueta

Publisher

Elsevier BV

Subject

General Medicine

Reference34 articles.

1. Squamous cell carcinoma of the lung: molecular subtypes and therapeutic opportunities;Perez-Moreno;Clin Cancer Res,2012

2. Metastatic non-small cell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up;Planchard;Ann Oncol,2019

3. Metastatic non-small cell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up;Planchard;Ann Oncol,2018

4. Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial;Mok;Lancet,2019

5. LBA78 - IMpower110: interim overall survival (OS) analysis of a phase III study of atezolizumab (atezo) vs platinum-based chemotherapy (chemo) as first-line (1L) treatment (tx) in PD-L1–selected NSCLC;Spigel;Ann Oncol,2019

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lung-MAP Next-Generation Sequencing Analysis of Advanced Squamous Cell Lung Cancers (SWOG S1400);Journal of Thoracic Oncology;2024-08

2. The difference between dacomitinib and afatinib in effectiveness and safety in first-line treatment of patients with advanced EGFR-mutant non-small cell lung cancer: a real-world observational study;BMC Cancer;2024-02-19

3. Targeting epidermal growth factor receptor signalling pathway: A promising therapeutic option for COVID‐19;Reviews in Medical Virology;2023-12-21

4. Detection of Activated Receptor Tyrosine Kinases in Human Lung Squamous Cell Carcinoma;2023-02-08

5. Squamous Cell Carcinoma;Diagnostic Imaging of Lung Cancers;2023